{"abstract":"The Food and Drug Administration (FDA) is providing interested persons with the opportunity to submit written comments concerning recommendations by the World Health Organization (WHO) to impose international manufacturing and distributing restrictions, under international treaties, on certain drug substances. The comments received in response to this notice will be considered in preparing the United States' position on these proposals for a meeting of the United Nations Commission on Narcotic Drugs (CND) in Vienna, Austria, in March 2024. This notice is issued under the Controlled Substances Act (CSA).","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2024/02/08/2024-02573.html","cfr_references":[],"citation":"89 FR 8683","comment_url":null,"comments_close_on":"2024-02-27","correction_of":null,"corrections":[],"dates":"Submit either electronic or written comments by February 27, 2024.","disposition_notes":null,"docket_ids":["Docket No. FDA-2022-N-0105"],"dockets":[{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":2,"comment_start_date":"2024-02-08","updated_at":"2024-02-28T00:01:41.048-05:00","comment_url":"https://www.regulations.gov/commenton/FDA-2022-N-0105-0006","allow_late_comments":null,"id":"FDA-2022-N-0105-0006","comment_end_date":"2024-02-28","regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2022-N-0105","title":"International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; World Health Organization; Scheduling Recommendations; Brorphine; Metonitazene; Eutylone; Request for Comments"}],"document_number":"2024-02573","effective_on":null,"end_page":8689,"executive_order_notes":null,"executive_order_number":null,"explanation":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2024/02/08/2024-02573.xml","html_url":"https://www.federalregister.gov/documents/2024/02/08/2024-02573/international-drug-scheduling-convention-on-psychotropic-substances-single-convention-on-narcotic","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2024-02573?publication_date=2024-02-08","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2024-02-08/2024-02573/mods.xml","not_received_for_publication":null,"page_length":7,"page_views":{"count":1001,"last_updated":"2026-04-04 16:15:04 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-02-08/pdf/2024-02573.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-02573.pdf?1707313525","publication_date":"2024-02-08","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2024/02/08/2024-02573.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_count":2,"agency_id":"FDA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2022-N-0105","supporting_documents_count":0,"docket_id":"FDA-2022-N-0105","document_id":"FDA-2022-N-0105-0006","regulation_id_number":null,"title":"International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; World Health Organization; Scheduling Recommendations; Brorphine; Metonitazene; Eutylone; Request for Comments","checked_regulationsdotgov_at":"2024-02-29T02:00:06Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":8683,"subtype":null,"title":"International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; World Health Organization; Scheduling Recommendations; Butonitazene; 3-Chloromethcathinone; Dipentylone; 2-Fluorodeschloroketamine; Bromazolam; Request for Comments","toc_doc":"Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; World Health Organization; Scheduling Recommendations; Butonitazene; 3-Chloromethcathinone; Dipentylone; 2-Fluorodeschloroketamine; Bromazolam","toc_subject":"International Drug Scheduling:\n","topics":[],"type":"Notice","volume":89}